DBS
Advancing Deep Brain Stimulation Through Better Targeting and Smarter Devices
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-26-PA-23Jun 26, 2026
CNS Clinical
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969
Insilico Medicine
PR-06-26-01Jun 17, 2026
Protein Misfolding
Protein Misfolding as a Therapeutic Axis in Neurodegenerative Disease
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-08Jun 15, 2026
Alzheimer Therapies
Beyond Amyloid: Building the Next Alzheimer’s Disease Therapeutic Ecosystem
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-05Jun 10, 2026